mastering psychopharmacology dsm˜5® ce dsm˜5® d˜10

2
• Differential diagnoses for child, adolescent, and adult mental disorders • Accurate selection of ICD-10 codes for DSM-5® mental disorders • Apply a Four-Step Diagnostic Method • Frequent comorbid mental disorders • Intake interview strategies • Using assessment tools to improve diagnosis • Current neuroscience underlying DSM-5® disorders and the use of psychotropics • Effective medications for DSM-5® disorders • Alternative treatments when standard medications fail • Strategies for predicting and preventing prescription drug abuse DSM-5® & ICD-10 Mastering Day 1 Day 2 PSYCHOPHARMACOLOGY for Mental Health Professionals Diagnosis A Symptom-Based Approach SAN DIEGO, CA Thursday & Friday August 24 & 25, 2017 A NON-PROFIT ORGANIZATION CONNECTING KNOWLEDGE WITH NEED SINCE 1979 www.pesi.com Register now! pesi.com/express/55626 Register now! pesi.com/express/55626 Day 1 Day 2 DSM-5® & ICD-10 Mastering Diagnosis A Symptom-Based Approach PSYCHOPHARMACOLOGY for Mental Health Professionals SAN DIEGO, CA Thursday & Friday August 24 & 25, 2017 www.pesi.com/inhouse Earn CE where you work! Bring this training & many others to your facility go.pesi.com/BESSELCE A Bold New Paradigm For Healing Trauma 1 HOUR VIDEO BESSEL VAN DER KOLK HURRY OFFER EXPIRES July 15, 2017 FREE CE 1. Apply a four-step diagnostic method process to identify and code a client’s diagnosis. 2. Specify DSM-5® key symptoms and diagnostic criteria for frequently diagnosed mental disorders. 3. Determine important differential diagnoses for anxiety, depressive, trauma-related, substance-related, and neurodevelopmental disorders. 4. Analyze differential diagnoses for children with a symptom of disruptive behavior. 5. Diagnose clients with overlapping symptoms or comorbid conditions. 6. Use the DSM-5® severity tables, assessment tools, and coding notes to improve diagnosis and ICD-10 coding. DSM-5® and ICD-10 Diagnosis Quick Review Use of criteria sets, specifiers, and coding notes Options if diagnosis unclear Combining ICD-10 and the DSM-5® to code and name mental disorders Online DSM resources and diagnosis updates Four-Step Diagnostic Method Goals of the intake interview Steps to a DSM-5® diagnosis Broad opening: client behavior sample Identifying key DSM-5® symptom clusters Differential diagnosis Focused interviewing for specific disorders Four-Steps case example Assessment Tools for Diagnosis DSM-5® cross-cutting symptom measures and screening tools Assessments for alcohol, drug and tobacco use Differential Diagnosis of Specific DSM-5® Mental Disorders Depression Major Depressive Disorder vs. Persistent Depressive Disorder Major Depressive Disorder vs. Bipolar II Disorder Depressive disorders vs. Anxiety Disorders Depressive disorders vs. Adjustment Disorder Medical conditions with depressive symptoms Frequent comorbid disorders Comparing the cases of Winona and Frank Fear and Anxiety Generalized Anxiety Disorder vs. Social Anxiety Disorder Panic Disorder vs. Medication Induced Anxiety Generalized Anxiety Disorder vs. Somatic Symptom Disorder Medical conditions with anxiety symptoms Frequent comorbid disorders Case: “Carlos hates shopping” Abnormal or Impaired Cognition Case: “What is wrong with my son?” Psychosis as a key symptom Schizophrenia Spectrum disorders vs. Bipolar disorders Schizoaffective Disorder vs. Schizophrenia Comorbid substance use disorders Cognitive Deficits as a key symptom Neurodevelopmental disorders Autism Spectrum Disorder Attention Deficit/Hyperactivity Disorder Neurocognitive disorders Repetitive Thoughts and Behaviors Obsessive-Compulsive Disorder vs. Anxiety disorders Body Dysmorphic Disorder vs. Eating disorders Hoarding Excoriation disorders vs. Non-suicidal Self-injury Frequent comorbid disorders Experiences of Stress and Trauma Trauma as a catalyst for mental disorders Posttraumatic Stress Disorder differential diagnosis Adjustment disorders differential diagnosis Frequent comorbid disorders Case: Lt. Brown Substance Use or Addictive Behaviors Substance Use disorders as a catalyst for other mental disorders Gambling Disorder as an addiction Substance use and comorbid disorders Current drugs in America quiz Children with Disruptive Behaviors Disruptive Mood Dysregulation Disorder vs. Oppositional Defiant Disorder Reactive Attachment Disorder ODD or Conduct Disorder vs. Attention Deficit/Hyper activity Disorder Frequent comorbid disorders Outline Objectives Outline Day 1 Day 2 1. Communicate the neurotransmitter systems and neuroanatomy underlying the biological basis for mental disorders and pharmacotherapy. 2. Evaluate the role of mental health professionals with clients receiving both psychotherapeutic medications and psychotherapy. 3. Analyze the major classes of drugs used to treat mental disorders and which mental disorders are appropriately treated with each class of drugs. 4. Compare and contrast the effects/side effects of antipsychotics, antidepressants, benzodiazepines and other antianxiety agents, anticonvulsants and drugs used to treat other mental disorders including OCD, ADHD, and cognitive impairment. 5. Determine the abuse liability of drugs used in the treatment of anxiety, insomnia, pain and ADHD. 6. Implement methods for prevention and early identification of prescription drug abuse. PSYCHOPHARMACOLOGICAL FOUNDATIONS • Neurobiology of Behavior, Mental Illness & Psychotherapeutic Drug Action Brain structures & circuits involved in: Emotional regulation Executive function & inhibitory control Reward & pleasure Learning & memory Neurotransmitters important in the actions of psychopharmacological agents Biogenic amines Excitatory & inhibitory neurotransmitters Endorphins & endocannabinoids • Your role in combined psychological & pharmacological treatments Collaboration & communication with prescribing professionals Managing the combined treatments Referrals for medication Client psycho-education Monitoring drug effects & side effects Promoting adherence to combined treatments DRUGS USED IN THE TREATMENT OF DSM-5® MENTAL DISORDERS • Schizophrenia Spectrum Disorders Biological theories of schizophrenia “Typical” & “atypical” antipsychotic drugs Effects, side effects & cautions – similarities & differences Latest evidence-based comparisons Drugs for treatment-resistant schizophrenia Other uses of antipsychotic drugs • Depressive Disorders Neurobiology of depression Drugs used to treat depressive disorders Selective Serotonin Reuptake Inhibitors (SSRIs) Effects Side effects & cautions including suicide risk & discontinuation syndrome Serotonin syndrome Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) Effects Side effects & cautions Atypical antidepressant agents Effects Side effects & cautions Tricyclic antidepressants (TCAs) - effect, side effects & cautions: Why were newer drugs needed Choosing an antidepressant What if first-line antidepressants do not work? MAO Inhibitors Augmentation with antipsychotics Other physiological & pharmacological treatments What about herbs like St. John’s Wort? • Bipolar Disorders Biological theories for bipolar disorders Drugs used to treat bipolar disorders A prototype agent Anticonvulsants – effects, side effects & cautions Antipsychotics – approved agents Combination drug therapy • Anxiety, Obsessive-Compulsive & Sleep-Wake Disorders The neurobiology of anxiety-related disorders The anxiety disorders Obsessive-compulsive disorder The structure of sleep Drugs used in the treatment of anxiety & insomnia Benzodiazepines & Benzodiazepine-like drugs Misuse of these drugs in treatment SSRI’s & other drugs used to treat anxiety Drugs used to treat OCD (SSRIs etc.) • Attention-Deficit/Hyperactivity Disorder & Neurocognitive Disorders (Dementia) ADHD Psycho-stimulants – their effects, side effects & cautions Antidepressants & Alpha-Adrenergic Agonists Major neurocognitive disorders Drugs used in the treatment of cognitive impairment Future treatments • Prescription Drug Abuse Mental disorders & risk of comorbid prescription drug abuse Classes of drugs that are frequently abused Stimulants Sedative-hypnotics Opiates Prevention & early identification of prescription drug abuse Objectives DSM-5® & ICD-10 Mastering Diagnosis PSYCHOPHARMACOLOGY for Mental Health Professionals 55626 PESI P.O. Box 1000 Eau Claire, WI 54702-1000 A division of PESI, Inc. NON-PROFIT ORG US POSTAGE PAID EAU CLAIRE WI PERMIT NO 32729 Don’t forget to bring your DSM-5® Manual Earn up to 6.3 CE hours of Pharmacology Attend both days and SAVE! Earn up to CE hours of Pharmacology credit 6.3

Upload: others

Post on 25-Feb-2022

20 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Mastering PSYCHOPHARMACOLOGY DSM˜5® CE DSM˜5® D˜10

• Differential diagnoses for child, adolescent, and adult mental disorders

• Accurate selection of ICD-10 codes for DSM-5® mental

disorders• Apply a Four-Step Diagnostic

Method

• Frequent comorbid mental disorders

• Intake interview strategies• Using assessment tools to

improve diagnosis

• Current neuroscience underlying DSM-5® disorders and the use of psychotropics

• Effective medications for DSM-5® disorders

• Alternative treatments when standard medications fail

• Strategies for predicting and preventing prescription drug abuse

DSM-5® & ICD-10Mastering

Day 1

Day 2

PSYCHOPHARMACOLOGYfor Mental Health Professionals

DiagnosisA Symptom-Based Approach

SAN DIEGO, CA Thursday & Friday

August 24 & 25, 2017

A NoN-Profit orgANizAtioN CoNNeCtiNg KNowledge with Need SiNCe 1979 www.pesi.com

Register now! pesi.com/express/55626Register now! pesi.com/express/55626

Day 1

Day 2

DSM-5® & ICD-10Mastering

DiagnosisA Symptom-Based Approach

PSYCHOPHARMACOLOGYfor Mental Health Professionals

SAN DIEGO, CA Thursday & Friday

August 24 & 25, 2017

www.pesi.com/inhouse

Earn CE where you work! Bring thistraining & many others to your facility

go.pesi.com/BESSELCE

A Bold New Paradigm For Healing Trauma

1 HOUR VIDEOBessel van der KolK

HURRY OFFER EXPIRES

J u l y 15, 2 017

FREECE

1. Apply a four-step diagnostic method process to identify and code a client’s diagnosis.

2. Specify DSM-5® key symptoms and diagnostic criteria for frequently diagnosed mental disorders.

3. Determine important differential diagnoses for anxiety, depressive, trauma-related, substance-related, and neurodevelopmental disorders.

4. Analyze differential diagnoses for children with a symptom of disruptive behavior.

5. Diagnose clients with overlapping symptoms or comorbid conditions.

6. Use the DSM-5® severity tables, assessment tools, and coding notes to improve diagnosis and ICD-10 coding.

DSM-5® and ICD-10 Diagnosis Quick ReviewUse of criteria sets, specifiers, and coding notesOptions if diagnosis unclearCombining ICD-10 and the DSM-5® to code and name mental disordersOnline DSM resources and diagnosis updates

Four-Step Diagnostic MethodGoals of the intake interviewSteps to a DSM-5® diagnosis Broad opening: client behavior sample Identifying key DSM-5® symptom clusters Differential diagnosis Focused interviewing for specific disordersFour-Steps case example

Assessment Tools for DiagnosisDSM-5® cross-cutting symptom measures and screening toolsAssessments for alcohol, drug and tobacco use

Differential Diagnosis of Specific DSM-5® Mental DisordersDepression Major Depressive Disorder vs. Persistent Depressive DisorderMajor Depressive Disorder vs. Bipolar II DisorderDepressive disorders vs. Anxiety DisordersDepressive disorders vs. Adjustment DisorderMedical conditions with depressive symptomsFrequent comorbid disordersComparing the cases of Winona and FrankFear and Anxiety Generalized Anxiety Disorder vs. Social Anxiety DisorderPanic Disorder vs. Medication Induced AnxietyGeneralized Anxiety Disorder vs. Somatic Symptom Disorder Medical conditions with anxiety symptomsFrequent comorbid disordersCase: “Carlos hates shopping”

Abnormal or Impaired CognitionCase: “What is wrong with my son?”Psychosis as a key symptom Schizophrenia Spectrum disorders vs. Bipolar disorders Schizoaffective Disorder vs. Schizophrenia Comorbid substance use disordersCognitive Deficits as a key symptom Neurodevelopmental disorders Autism Spectrum Disorder Attention Deficit/Hyperactivity Disorder Neurocognitive disordersRepetitive Thoughts and BehaviorsObsessive-Compulsive Disorder vs. Anxiety disordersBody Dysmorphic Disorder vs. Eating disordersHoarding Excoriation disorders vs. Non-suicidal Self-injuryFrequent comorbid disordersExperiences of Stress and Trauma Trauma as a catalyst for mental disordersPosttraumatic Stress Disorder differential diagnosisAdjustment disorders differential diagnosisFrequent comorbid disordersCase: Lt. BrownSubstance Use or Addictive Behaviors Substance Use disorders as a catalyst for other mental disordersGambling Disorder as an addiction Substance use and comorbid disorders Current drugs in America quizChildren with Disruptive BehaviorsDisruptive Mood Dysregulation Disorder vs. Oppositional Defiant DisorderReactive Attachment Disorder ODD or Conduct Disorder vs. Attention Deficit/Hyper activity DisorderFrequent comorbid disorders

Outline

Objectives

OutlineDay 1 Day 2

1. Communicate the neurotransmitter systems and neuroanatomy underlying the biological basis for mental disorders and pharmacotherapy.

2. Evaluate the role of mental health professionals with clients receiving both psychotherapeutic medications and psychotherapy.

3. Analyze the major classes of drugs used to treat mental disorders and which mental disorders are appropriately treated with each class of drugs.

4. Compare and contrast the effects/side effects of antipsychotics, antidepressants, benzodiazepines and other antianxiety agents, anticonvulsants and drugs used to treat other mental disorders including OCD, ADHD, and cognitive impairment.

5. Determine the abuse liability of drugs used in the treatment of anxiety, insomnia, pain and ADHD.

6. Implement methods for prevention and early identification of prescription drug abuse.

PSYCHOPHARMACOLOGICAL FOUNDATIONS• Neurobiology of Behavior, Mental Illness &

Psychotherapeutic Drug Action Brain structures & circuits involved in: Emotional regulation Executive function & inhibitory control Reward & pleasure Learning & memory Neurotransmitters important in the actions of psychopharmacological agents Biogenic amines Excitatory & inhibitory neurotransmitters Endorphins & endocannabinoids• Your role in combined psychological &

pharmacological treatments Collaboration & communication with prescribing professionals Managing the combined treatments Referrals for medication Client psycho-education Monitoring drug effects & side effects Promoting adherence to combined treatments DRUGS USED IN THE TREATMENT OF DSM-5® MENTAL DISORDERS• Schizophrenia Spectrum Disorders Biological theories of schizophrenia “Typical” & “atypical” antipsychotic drugs Effects, side effects & cautions – similarities & differences Latest evidence-based comparisons Drugs for treatment-resistant schizophrenia Other uses of antipsychotic drugs • Depressive Disorders Neurobiology of depression Drugs used to treat depressive disorders Selective Serotonin Reuptake Inhibitors (SSRIs) Effects Side effects & cautions including suicide risk & discontinuation syndrome Serotonin syndrome Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) Effects Side effects & cautions Atypical antidepressant agents Effects Side effects & cautions Tricyclic antidepressants (TCAs) - effect, side effects & cautions: Why were newer drugs needed

Choosing an antidepressant What if first-line antidepressants do not work? MAO Inhibitors Augmentation with antipsychotics Other physiological & pharmacological treatments What about herbs like St. John’s Wort?• Bipolar Disorders Biological theories for bipolar disorders Drugs used to treat bipolar disorders A prototype agent Anticonvulsants – effects, side effects & cautions Antipsychotics – approved agents Combination drug therapy• Anxiety, Obsessive-Compulsive & Sleep-Wake

Disorders The neurobiology of anxiety-related disorders The anxiety disorders Obsessive-compulsive disorder The structure of sleep Drugs used in the treatment of anxiety & insomnia Benzodiazepines & Benzodiazepine-like drugs Misuse of these drugs in treatment SSRI’s & other drugs used to treat anxiety Drugs used to treat OCD (SSRIs etc.)• Attention-Deficit/Hyperactivity Disorder &

Neurocognitive Disorders (Dementia) ADHD Psycho-stimulants – their effects, side effects & cautions Antidepressants & Alpha-Adrenergic Agonists Major neurocognitive disorders Drugs used in the treatment of cognitive impairment Future treatments• Prescription Drug Abuse Mental disorders & risk of comorbid prescription drug abuse Classes of drugs that are frequently abused Stimulants Sedative-hypnotics Opiates Prevention & early identification of

prescription drug abuse

Objectives

DSM-5® & ICD-10Mastering

Diagnosis

PSYCHOPHARMACOLOGYfor Mental Health Professionals

55626

PESI

P.O. B

ox 10

00

Eau

Clair

e, W

I 547

02-1

000

A divi

sion o

f PES

I, Inc

.

NO

N-P

ROFI

T O

RG

US

POST

AG

E PA

IDEA

U C

LAIR

E W

I PE

RMIT

NO

327

29

Don’t forget to bring your DSM-5® Manual

Earn up to 6.3 CE hours of Pharmacology

Attend both days and SAVE!

Earn up to

CE hours of Pharmacologycredit

6.3

Page 2: Mastering PSYCHOPHARMACOLOGY DSM˜5® CE DSM˜5® D˜10

Speakers

Take your DSM-5® diagnostic skills to the next level! This advanced seminar is designed specifically for mental health professionals seeking to master clinical diagnosis and differential diagnosis using the DSM-5®, ICD-10 and online assessment tools. The focus of this workshop is on the key symptoms for each diagnosis, common differential diagnoses and frequent comorbid disorders of anxiety, depressive, trauma-related, substance-related, psychotic and neurodevelopmental disorders. Case examples and studies are provided throughout - giving you the opportunity to learn and apply a four-step symptoms-based diagnostic method. Topics include the clinical intake interview, differential diagnoses, online assessment tools to narrow diagnosis and potential comorbidities.

DSM-5® & ICD-10Mastering

Diagnosis

Margaret (Peggy) L. Bloom, Ph.D., a licensed psychologist and NCC, is a professor emerita of counselor education and counseling psychology at Marquette University in Milwaukee, Wisconsin where she taught psychopathology, diagnosis and assessment and foundations of clinical mental health counseling. Previously she served on the faculties of Loyola University, Chicago, University of Memphis, Boston University, Overseas, and the University of Florida. Peggy is nationally recognized for her knowledge and expertise in assessment, DSM diagnosis and in counselor education. She is an appointed member of the board of the Center for Credentialing & Education (National Board for Certified Counselors), an elected fellow of the American Psychological Association and a past-president of the Association for Counselor Education and Supervision. Peggy has published numerous journal articles and made professional presentations across the world. Beginning with the introduction of the DSM-III-R, then the DSM-IV, and now the DSM-5®, Dr. Bloom has conducted DSM seminars across the United States for hundreds of psychologists, professional counselors, social workers and other mental health professionals. Peggy brings a unique interdisciplinary perspective to each DSM seminar. She began her career as a psychiatric nurse and earned graduate degrees in nursing, counseling, and counseling psychology. For a number of years she maintained a private therapy practice in addition to her university positions. Bloom received her bachelor of science in nursing (with distinction) from the State University of New York at Buffalo, a master of science in psychiatric nursing from the University of California at San Francisco and a master’s in counseling and guidance from the University of Hawaii. She earned her Ph.D. in counseling psychology (education) from Arizona State University in Tempe. She also holds certificates in management and leadership in education from Harvard University.Speaker Disclosure: Financial: Financial: Margaret Bloom is a Professor of Counselor Education and Counseling Psychology at Marquette University. She receives a speaking honorarium from PESI, Inc.Non-financial: Margaret Bloom has no relevant non-financial relationship to disclose.

Alan S. Bloom, Ph.D., is professor of pharmacology and toxicology at the Medical College of Wisconsin where he teaches psychopharmacology to medical students and neuroscience graduate students. He earned a dual Ph.D. in psychology and pharmacology and consults regularly with psychiatrists and attorneys in drug abuse and other pharmacology related cases. For the past 20 years he has conducted research on the impact of drugs of abuse (marijuana, cocaine, etc.) on the brain through use of functional magnetic resonance imaging (fMRI). He directs research on the cognitive effects of chemotherapy drugs administered to women with breast cancer, commonly known as “chemo-brain”. His studies have been funded by the NIH and other national organizations and reported in an extensive number of publications and presentations. Dr. Bloom has served on the NIDA Center grant review panel and is an appointed member of the Controlled Substance Board of the State of Wisconsin.He is a strong and experienced presenter providing lively, information-packed seminars. Dr. Bloom encourages the active learning of participants through application of the material in case studies and problem-based learning. In 1997 he was elected to membership in the Medical College of Wisconsin Society of Teaching Scholars. Speaker Disclosure:

Financial: Alan Bloom is a Professor of Pharmacology and Toxicology at the Medical College of Wisconsin. He receives a speaking honorarium from PESI, Inc.

Non-financial: Alan Bloom is the vice-chair for the State of Wisconsin Controlled Substances Board.

Day 2Most clients with DSM-5® diagnoses are being treated with a combination of psychological and pharmacological treatments. Newer drugs are being developed to treat mental disorders based on a better understanding of neurobiological contributions to mental disorders and the latest pharmacological research. To provide appropriate services, you are expected to have a thorough understanding of these common and complex issues. As a mental health professional, keeping up-to-date is essential.

This seminar will update and increase your knowledge of:

• Neurobiological underpinnings of major DSM-5® diagnoses

• Effects and side effects of drugs used to treat these diagnoses

• Responsibilities of the non-prescribing therapist to clients taking psychiatric medication

Specifics of the pharmacological treatment and drugs of choice for Depressive, Bipolar, Schizophrenia Spectrum, Anxiety, OCD, Sleep-Wake, ADHD and Neurocognitive disorders will be presented. Unique to this seminar is information on the common types of psychotherapeutic drugs and other drugs that are abused, and methods for prevention and early detection. Throughout the day, representative case studies will generate discussion and examination of the latest drug treatment for DSM-5® disorders. You will leave this seminar with knowledge and confidence regarding effective and safe application of pharmacological drugs.

PSYCHOPHARMACOLOGYfor Mental Health Professionals

Seminar Schedule Both Days: 7:30 Registration/Morning Coffee & Tea8:00 Program begins11:50-1:00 Lunch (on your own)4:00 Program endsFor locations and maps, go to www.pesi.com, find your event, and click on the seminar title.

Seminar on DVD or CD Package: You can purchase a self-study package on the subject. You will receive a set of CDs or DVDs that include a digital copy of the seminar manual and post-test/evaluation. You and your colleagues can receive CE hours for a nominal fee. To determine if homestudy credits are available for your profession go to www.pesi.com or call 800-844-8260. Check with your licensing board to verify acceptance of self-study credits for license renewal. Order today by using the order form on this brochure or by calling 800-844-8260.

Hassle-Free Cancellation Policy: If you contact us before the event date, you can exchange for a DVD or CD/digital manual package on the subject (self-study continuing education credit may be available), a certificate to attend another seminar, or receive a tuition refund less a $30/day cancel fee. Substitutions are permitted at any time.

Credits listed below are for full attendance at the live event only. Certificates of Completion are distributed at the conclusion of the live seminar for those who register prior to the event date and attend the full day. A letter of attendance will be issued to participants who register at the event, arrive late, or leave early. For those who registered day of (walk-ins), and are in full attendance, a certificate of completion for full CE credit will be sent within 30 days following the event. For those in partial attendance (arrived late or left early), an adjusted certificate of completion reflecting partial credit will be issued within 30 days (if your board allows). Please see “live seminar schedule” for full attendance start and end times. NOTE: Boards do not allow credit for breaks or lunch.

If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, or questions on home study credit availability, please contact [email protected] or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of mental health professionals. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your professions standards.

PESI, Inc. offers continuing education programs and products under the brand names PESI, PESI Healthcare, PESI Rehab and Psychotherapy Networker.COUNSELORS: This activity consists of 6.25 clock hours per day OR 12.5 clock hours for entire conference of continuing education instruction. Credit requirements and approv-als vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.SOCIAL WORKERS: PESI, Inc. Provider #:1062, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB), www.aswb.org through the Approved Continuing Education (ACE) Program. PESI, Inc. maintains responsibility for the program. ASWB Approval Period: January 27, 2014-January 27, 2017. Social workers should contact their regulatory board to determine course approval for continuing education credits. Social workers participating in this course will receive 6.25 (Clinical) continuing education clock hours per day OR 12.5 (Clinical) continuing education clock hours for entire conference for this intermediate course. A certificate of attendance will be awarded at the end of the program to social workers who complete the program evaluation.CALIFORNIA SOCIAL WORKERS/COUNSELORS/MARRIAGE & FAMILY THERA-PISTS/LICENSED EDUCATIONAL PSYCHOLOGISTS: The State of California, Board of Behavioral Sciences will recognize and accept continuing education programs that are sponsored by providers approved by the American Psychological Association and the ASWB. Full attendance at this course will qualify for 6.0 hours of continuing education credit per day OR 12.0 hours of continuing education credit for entire conference.PSYCHOLOGISTS: PESI, Inc. is approved by the American Psychological Association to sponsor continuing education for psychologists. PESI maintains responsibility for this program and its content. PESI is offering this activity for 6.25 hours of continuing education credit per day OR 12.5 hours of continuing education credit for entire conference. Full attendance is required; no partial credits will be offered for partial attendance.MARRIAGE AND FAMILY THERAPISTS: This activity consists of 380 minutes of continuing education instruction per day OR 760 minutes of continuing education instruction for entire conference. Credit requirements and approvals vary per state board regulations. You should save this course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.

ADDICTION COUNSELORS: This course has been approved by PESI, Inc., as a NAADAC Approved Education Provider, for 6.0 CE per day OR 12.5 CE for entire course in the Treatment Plan skill group. NAADAC Provider #77553. PESI, Inc. is responsible for all aspects of their programming. Full attendance is required; no partial credit will be awarded for partial attendance.CALIFORNIA ALCOHOLISM & DRUG ABUSE COUNSELORS: PESI, Inc. is an approved provider with the California Association of Alcoholism and Drug Abuse Counselors (CAADAC) Provider #: OS-03-036-1017. This course meets the qualifications for 6.0 hours of continuing education credit per day OR 12.0 hours of continuing education credit for entire conference. NURSES/NURSE PRACTITIONERS/CLINICAL NURSE SPECIALISTS: This activity meets the criteria for a formally approved American Nurses Credentialing Center (ANCC) Activ-ity PESI, Inc, is an approved provider by the American Psychological Association, which is recognized by the ANCC for behavioral health related activities. Full attendance is required; no partial credit will be awarded for partial attendance.This activity qualifies for 6.25 contact hours per day OR 12.5 contact hours for entire conference. CALIFORNIA NURSES: PESI, Inc. is a provider approved by the California Board of Reg-istered Nursing, Provider Number 13305 for 6.0 contact hours per day OR 12.0 contact hours for entire conference. Full attendance is required. No partial contact hours will be issued for partial attendance. Please bring your license number to the seminar; certifi-cates of successful completion will not be issued without your license number.OCCUPATIONAL THERAPISTS & OCCUPATIONAL THER-APY ASSISTANTS: PESI, Inc. is an AOTA Approved Provider of continuing education. Provider #: 3322. Full attendance at this course qualifies for 6.0 contact hours or .6 CEUs per day OR 12.0 contact hours or 1.20 CEUs for entire conference in the Category of Domain of OT and Occupational Therapy Process. Partial credit will be issued for partial atten-dance. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA. Course Level: Intermediate.Available for Psychopharmacology Day 2 onlyNURSES/NURSE PRACTITIONER/CLINICAL NURSE SPECIALISTS: PESI, Inc. is accredit-ed as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses in full attendance will earn 6.3 contact hours. PARTIAL CONTACT HOURS WILL BE AWARDED FOR PARTIAL ATTENDANCE. Available for Psychopharmacology Day 2 onlyNURSE PRACTITIONERS: This program offers 380 instructional minutes of pharmacol-ogy content which is designed to qualify for 6.3 contact hours toward your pharmacol-ogy requirement to receive credit. It is your responsibility to submit your certificate of successful completion and a copy of the seminar brochure to your licensing board. Available for Psychopharmacology Day 2 onlyPHARMACISTS: PESI, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this Knowledge-based activity qualifies for 6.3 contact hours. ACPE Universal Program Number: 0289-0000-15-037-L01-P. Full attendance is required. No partial contact hours will be awarded for partial attendance. You are required to complete a program evaluation/post-test and bring your e-Profile ID to the seminar to receive CPE credit. Don’t have your e-Profile ID yet? Visit the National Association of Boards of Pharmacy (NABP) website and complete your e-profile at www.nabp.net in order to obtain your NABP e-Profile ID.OTHER PROFESSIONS: This seminar qualifies for 380 continuing education clock hours per day OR 760 continuing education clock hours for entire conference as required by many national, state and local licensing boards and professional organizations. Save your course outline and certificate of completion, and contact your own board or organization for specific requirements.

Live Seminar Continuing Education Credit Information for Each Day

Have a seminar idea? A manuscript to publish? The nation’s top speakers and authors contact us first. If you are interested in becoming a speaker, or have a new topic idea, please contact Teresa Fisher at [email protected] or call (715) 855-8214.

Counselors • Social Workers • Psychologists • Psychotherapists • Case Managers • Addiction Counselors Therapists • Marriage & Family Therapists • Nurses • Nurse Practitioners • Clinical Nurse Specialists • Pharmacists Other Mental Health Professionals

Target Audience

*SAVE BY INCLUDING THESE BOOKS WITH SEMINAR REGISTRATION*

Psychopharmacology Straight Talk on Mental Health Medications - Third Edition

By Joseph F. Wegmann, Pharm.D., LCSWA definitive guide to expand your knowledge in the pharmacological and behavioral treatment of psychosis, anxiety, depression, bipolar, insomnia and ADHD. Updates for the third edition include DSM-5® applications, newly released psychiatric meds, new risk factors with antidepressants, and the latest in geriatric psychopharmacology.

Questions? Call customer service at 800-844-8260

Day 1

Mastering the DSM-5®:Integrating New & Essential Measures Into Your PracticeBy Mary Flett, Ph.D.Mastering the DSM-5® provides a guide for each of the assessment measures, examples of how they can be implemented for various populations and settings, and suggestions for using evaluation tools with clients. Easy to use with case studies and examples, also includes implementation checklists, templates to chart and measure results, and links to formatted excel spreadsheets.

� Please complete entire form (to notify you of seminar changes): please print; staple duplicate forms.

Mail Code: _______________________________ See mail code box on address panel on reverse side

Name ________________________________ Profession _____________________

Employer Name ______________________________________________________

Employer Address_____________________________________________________

Dept/Floor/Suite ______________________________________________________

City ______________________________ County __________________________

State ______________________________ Zip _____________________________

Home/Cell Ph ( ) _________________________________________________

Dept. Ph ( ) _____________________________________________________

E-mail address ______________________________________________________

For your convenience, confirmations are sent via email.

� Check tuition: TUITION WITH SEMINAR MANUAL

Day One only—Mastering DSM-5® and ICD-10 Diagnosis: A Symptom-Based Approach ■ $219.99 per person standard tuition

Day Two only—Psychopharmacology for Mental Health Professionals ■ $219.99 per person standard tuitionBoth Days: - Save $50

■ $389.98 per person standard tuition

Add-oN ProduCtSDistributed at seminar—FREE SHIPPING!

■ $24.99* Mastering the DSM-5® book

■ $24.99* Psychopharmacology, 3rd Edition book

■ $19.99* Eat Right, Feel Right book

*Attendees add applicable state and local taxes except in AK, DE, MT, NH, OR

� Indicate method of payment: ALL REGISTRATIONS MUST BE PREPAID. Purchase orders welcome (attach copy).

■ Check enclosed payable to PESI, Inc.

■ MC ■ VISA ■ AE ■ Discover Novus16 digits 13-16 digits 15 digits 16 digits

Card # _____________________________________

Card Exp. ________________ V-Code #*: ______________

Signature___________________________________

(*MC/VISA/Discover: last 3-digit # on signature panel on back of card.)(*American Express: 4-digit # above account # on face of card.)

CAN'T ATTEND THE SEMINAR?See below for individual product orders

___ Mastering DSM-5® and ICD-10 Diagnosis (Day One) Seminar on DVD* (video) $199.99 (RNV051225)

___ Psychopharmacology for Mental Health Professionals (Day Two) Seminar on DVD* (video) $199.99 (RNV045905)

___ Mastering the DSM-5® book* $24.99 (PUB082830)

___ Psychopharmacology, 3rd Edition book* $24.99 (PUB083825)

___ Eat Right, Feel Right book* $19.99 (PUB084920)

*Shipping is $6.95 first item + $2.00 each add’l item.

**Residents add applicable state and local taxes except in AK, DE, MT, NH, OR

Product total $ ________ *Shipping __________ Subtotal __________ **Tax __________ TOTAL __________

DAY 1: MASTERING DSM-5® AND ICD-10 DIAGNOSIS: A SYMPTOM-BASED APPROACH

DAY 2: PSYCHOPHARMACOLOGY FOR MENTAL HEALTH PROFESSIONALS

800-844-8260Please have credit card available

800-554-9775

PESI PO BOX 1000 Eau Claire, WI 54702-1000

ONLINE

PHONE

FAX

MAIL

How to Register:

Fed ID # 26-3896894 © 2017 PESI, Inc.

TFfor offiCe uSe oNly

queStioNS? Call 800-844-8260 or e-mail us at [email protected].

� Check seminar(s): (make copy for your records)

SAN DIEGO, CACrowne Plaza San Diego-Mission Valley 2270 Hotel Circle North • 92108 • (619) 297-1101

DAY 1: Mastering DSM-5® and ICD-10 Diagnosis: A Symptom-Based Approach ■ August 24, 2017

DAY 2: Psychopharmacology for Mental Health Professionals

■ August 25, 2017

pesi.com/express/55626

We would be happy to accommodate your ADA needs; please call at least two weeks prior to the seminar date.

Walk-ins are welcome but admission cannot be guaranteed. Call M-F 7:00-6:00 Central Time for space availabil ity if registering within one week of seminar.

Tuition Options:$60 Tuition: If you are interested in being our registration coordinator for both days, go to: www.pesi.com/coord for availability and job description, or call our Customer Service Dept. at 800-844-8260.

Groups of 5 or more: Call 800-844-8260 for discounts.

Discounted Military Rate: PESI Inc. is proud to offer a $20 tuition discount on live seminar tuition for veterans and active duty military personnel. Advance registration by phone required.

Discounted Student Rate: As part of its mission to serve educational needs, PESI, Inc. offers a reduced rate of 50% off standard tuition for students. Enclose a current student schedule with registration form. Go to www.pesi.com/students or call 800-844-8260 for details.Advance registration required.Cannot be combined with other discounts.

Register now! pesi.com/express/55626

55626SDI

Don’t forget to bring your DSM-5® Manual

55626SDI

Disclaimer: DSM and DSM-5 are registered trademarks of the American Psychiatric Association. The American Psychiatric Association is not affiliated with nor endorses this seminar.

Eat Right, Feel Right 50 Recipes and Tips to Improve Mood, Sleep, Attention & FocusBy Leslie Korn, PH.D., MPH, LMHC Improve mood, sleep and focus with these 50 nutrient rich tips and easy recipes. Eat Right, Feel Right teaches you the do’s and don’ts of using ingredients in entrees, snacks, soups, smoothies and dressings to make you an at-home mental health chef.